The U-M Biointerfaces Institute welcomes Carl Gordon and Natasha Shervani of OrbiMed as new members of its External Advisory Board.
Biointerfaces Institute welcomes new members of its External Advisory Board
$2.38M to test nano-engineered brain cancer treatment in mice
A protein that crosses the blood-brain barrier carries a drug that kills tumor cells and another that activates the immune system.
Joerg Lahann receives funding to improve cancer-fighting technologies
U-M ChE’s Joerg Lahann, the Wolfgang Pauli Collegiate Professor of Chemical Engineering, has received funding for a joint industry-academic cancer research project with Gradalis. The research focuses on finding methods to utilize a patient’s cancer cells to create personalized therapeutics to treat cancer.
Joerg Lahann elected as an NAI Fellow
U-M ChE’s Joerg Lahann, the Wolfgang Pauli Collegiate Professor of Chemical Engineering, has been elected as a National Academy of Inventors (NAI) fellow in honor of his contributions to invention, innovative discovery, significant impacts on society and enhancement of innovation.
Patient cancer cells reliably grow on new 3D scaffold, showing promise for precision medicine
While previous structures guessed at the environment that cells would want, the new design lets the cells build to their own specifications.
Nanofiber carpet could mimic gecko feet, polar bear fur
A new technique that mimics biological nanofiber arrays can grow chain-like molecules into 3D nanostructures.
Microscale 3D printing for medicine
New “jet writing” technique can make detailed 3D structures with clinically relevant materials for future implants and cancer studies.
Bionic heart tissue: U-Michigan part of $20M center
Scar tissue left over from heart attacks creates dead zones that don’t beat. Bioengineered patches could fix that.
Coating method could improve temporary implants that dissolve in the body
Very even, pure coatings that promote healing may now be possible for biodegradable sutures and bone screws.
University of Michigan Biointerfaces Institute director Joerg Lahann knew from a young age that he wanted to be a chemist.